Granulomatous hepatitis due to combination of amoxicillin and clavulanic acid

C Silvain1, E Fort, P Levillain

  • 1Service d'Hépato-Gastro-Entérologie, CHU la Milétrie, Poitiers, France.

Insights

Amoxicillin-clavulanic acid can cause drug-induced liver injury, specifically hepatitis with granulomas. This finding expands understanding of the drug combination

Area of Science:

  • Hepatology
  • Clinical Pharmacology
  • Immunology

Background:

  • Amoxicillin-clavulanic acid is a widely prescribed antibiotic combination.
  • Drug-induced liver injury (DILI) is a significant concern with many medications.
  • The spectrum of DILI from amoxicillin-clavulanic acid is typically cholestatic.

Observation:

  • A case of amoxicillin-clavulanic acid-induced hepatitis presented with histological evidence of multiple granulomas.
  • The presence of granulomas and eosinophilia in liver biopsy suggests an immunoallergic mechanism.

Findings:

  • This case broadens the known spectrum of liver injury associated with amoxicillin-clavulanic acid.
  • The findings suggest that the amoxicillin component, potentially potentiated by clavulanic acid, may play a key role in inducing granulomatous hepatitis.

Implications:

  • This report highlights the need for increased awareness of granulomatous hepatitis as a potential adverse effect of amoxicillin-clavulanic acid.
  • Understanding the immunoallergic pathway may inform future drug development and patient monitoring strategies.
  • Further research is warranted to elucidate the precise mechanisms underlying amoxicillin-induced granulomatous liver injury.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...